Bing Center for Waldenstrom's Macroglobulinemia - Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.

You are here: Home

Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia.

Can't see this document? Click Here